Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
-4.35%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$70.7B
AUM Growth
-$13.8B
Cap. Flow
-$9.12B
Cap. Flow %
-12.91%
Top 10 Hldgs %
10.57%
Holding
4,619
New
443
Increased
1,322
Reduced
2,173
Closed
639

Sector Composition

1 Healthcare 19.38%
2 Technology 18.55%
3 Consumer Staples 10.17%
4 Consumer Discretionary 9.68%
5 Financials 8.23%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LLAP
3701
DELISTED
Terran Orbital Corporation
LLAP
$64K ﹤0.01%
+36,200
New +$64K
BLRX
3702
BioLineRX
BLRX
$18.1M
$63K ﹤0.01%
1,706
+562
+49% +$20.8K
VLN icon
3703
Valens Semiconductor
VLN
$197M
$62K ﹤0.01%
14,900
-93,000
-86% -$387K
XBIO icon
3704
Xenetic Biosciences
XBIO
$4.6M
$62K ﹤0.01%
11,510
-3,596
-24% -$19.4K
CAPR icon
3705
Capricor Therapeutics
CAPR
$289M
$61K ﹤0.01%
+10,200
New +$61K
OCUL icon
3706
Ocular Therapeutix
OCUL
$2.27B
$61K ﹤0.01%
14,793
-366,707
-96% -$1.51M
OTLK icon
3707
Outlook Therapeutics
OTLK
$44.4M
$61K ﹤0.01%
2,515
-8,055
-76% -$195K
CWBR
3708
DELISTED
CohBar, Inc. Common Stock
CWBR
$61K ﹤0.01%
21,123
-18,667
-47% -$53.9K
STSA
3709
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$60K ﹤0.01%
+10,000
New +$60K
BIVI icon
3710
BioVie
BIVI
$14.4M
$59K ﹤0.01%
235
+75
+47% +$18.8K
CLRB icon
3711
Cellectar Biosciences
CLRB
$16M
$59K ﹤0.01%
590
+35
+6% +$3.5K
WDH
3712
Waterdrop
WDH
$676M
$59K ﹤0.01%
54,100
-20,100
-27% -$21.9K
BPTH
3713
DELISTED
Bio-Path Holdings Inc
BPTH
$59K ﹤0.01%
930
+30
+3% +$1.9K
AHPI
3714
DELISTED
Allied Healthcare Products
AHPI
$59K ﹤0.01%
44,300
-16,300
-27% -$21.7K
BXRX
3715
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$59K ﹤0.01%
6,038
-1,974
-25% -$19.3K
IRS
3716
IRSA Inversiones y Representaciones
IRS
$991M
$58K ﹤0.01%
+13,731
New +$58K
PSNY icon
3717
Gores Guggenheim
PSNY
$2.02B
$58K ﹤0.01%
+11,400
New +$58K
TEO icon
3718
Telecom Argentina
TEO
$3.26B
$58K ﹤0.01%
14,500
-63,393
-81% -$254K
THRN
3719
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$58K ﹤0.01%
12,300
-34,500
-74% -$163K
PTE
3720
DELISTED
PolarityTE, Inc. Common Stock
PTE
$58K ﹤0.01%
67,222
+23,900
+55% +$20.6K
TIRX icon
3721
Tian Ruixiang Holdings
TIRX
$403M
$57K ﹤0.01%
3,676
-140
-4% -$2.17K
VRME icon
3722
VerifyMe
VRME
$10.7M
$57K ﹤0.01%
+44,400
New +$57K
AMBO
3723
Ambow Education Holding
AMBO
$10.2M
$56K ﹤0.01%
17,934
-830
-4% -$2.59K
ITRM icon
3724
Iterum Therapeutics
ITRM
$31M
$56K ﹤0.01%
34,684
+13,131
+61% +$21.2K
LGMK
3725
DELISTED
LogicMark
LGMK
$56K ﹤0.01%
149
+71
+91% +$26.7K